Start with the person
What problem is being looked at? What would a useful improvement look like? Those questions come before choosing a combination. Wanting better sleep or more energy doesn’t by itself tell us what treatment fits.
Medical history matters to that discussion. FDA’s ipamorelin assessment raises concerns about possible immune reactions and risks from raising growth hormone, including higher blood sugar. Long-term safety and safety in pregnancy aren’t established.
The conversation also needs room for alternatives, follow-up and deciding against treatment. A prescription can be the result of a review. It isn’t the result every request has to reach.
Then name the preparation
CJC-1295 with DAC and without DAC are different ingredients. Plain ipamorelin and ipamorelin acetate, its salt form, are distinct too. FDA’s CJC-1295 review and ipamorelin review explain those differences.
A compounded medicine is made to meet particular needs. It isn’t FDA-approved: FDA doesn’t check that it is safe, effective or well made before marketing. A prescription can’t supply that missing approval or evidence.
Access and approval are different questions
Promise Peptides offers prescription review for CJC-1295 with ipamorelin through the homepage invitation. A licensed U.S. clinician reviews each request and can decline it. Care is for U.S. patients, with state and treatment limits.
The FDA record needs its own space. On its page current as of April 22, 2026, ipamorelin acetate is in Category 2 under the 503B policy for outsourcing facilities. Its nomination for 503A, the patient-specific pharmacy route, was withdrawn. CJC-1295 also appears in the withdrawn-nominations table.
The groups that asked for the ingredients to be considered withdrew their requests. That isn’t FDA clearance or permission to compound. FDA gives no individual withdrawal dates. A listed service doesn’t settle which preparation is lawful or appropriate.
What could you ask?
Which exact ingredients are proposed, and why? What human evidence supports the hoped-for benefit? What alternatives are available, and how would problems be checked?
Those are conversation starters, not a test this page can pass for you. The pairing guide explains the evidence still missing for the combination. This is general information, with no personal medical or legal advice, and a product page can’t promise eligibility.